16th Winter Conference
on Medicinal & Bioorganic Chemistry
January 29th - February 2nd 2023
Steamboat Springs Resort, Colorado
Agenda
Sunday, January 29th 2023
Drug Hunting
Program Chair: Klemens Hoegenauer, Novartis
Title to be confirmed
Title to be confirmed
Title to be confirmed
Drug Hunter Award:
CGRP Receptor Antagonists for the Treatment of Migraine
Networking Session
Welcome Reception

Monday, January 30th 2023
Enabling Methodology and Technology
Program Chair: Iulia Strambeanu, Janssen
Mapping Chemical Space via High-throughput Experimentation: New Tools, New Reactions, and New Bicyclic Scaffolds
New Strategies for Redox Catalysis
Enabling and Accelerating Drug Discovery with High Throughput Chemistry
Impact of High Throughput Experimentation in Medicinal Chemistry at Vertex; from Microscale to Multigram
Discovery of Small Molecule Inhibitors Using a Modern Screening Paradigm and High Throughput Chemistry
Antivirals and Pandemic Diseases, Past, Present and Future
Program Chair: John McCauley, Merck
Title to be confirmed
Title to be confirmed
Title to be confirmed
Title to be confirmed
Tuesday, January 31st 2023
SynthChemBio
Program Chair: Niyi Fadeyi, InduPro
Title to be confirmed
Reactive Fragments in Covalent Drug Discovery
Title to be confirmed
Title to be confirmed
General Session: Synthesis and Med Chem
Program Chair: Amy Dounay, Colorado College
Networking Session
POSTER SESSION

Wednesday, February 1st 2023
Beyond Ro5 and Novel Modalities
Program Chair: Lou Chupak, Bristol Myers Squibb
Title to be confirmed
Title to be confirmed
MacMillan Alumni Session: Topics in Medicinal and Synthetic Chemistry
Program Chair: Mike VanHyest, GSK
Discovery of MK-6158 an oral, once daily, Soluble Guanylate Cyclase (sGC) Stimulator for the treatment of Pulmonary Arterial Hypertension
Discovery of Selective, CNS-Penetrant Covalent Inhibitors of Bruton’s Tyrosine Kinase for the Treatment of Multiple Sclerosis
Choose Your Own Adventure in Metal-Hydride Catalysis
Robert M. Williams' Memorial KEYNOTE LECTURE
Program Chair: Mike VanHeyest, GSK
The Development of Asymmetric Organocatalysis and Metallaphotoredox
Networking Session
Robert M. Williams' Memorial RECEPTION

Thursday, February 2nd 2023
Late Breaking Stories and 1st Disclosures
Program Chair: Dr Rebecca Gallego, Pfizer
Title to be confirmed
Potent Dual Plasmepsin IX/X Inhibitors towards the Treatment of Malaria
Title to be confirmed
Networking Session
Conference Dinner - Top of the Gondola

Media Sponsors


